REG - Fevertree Drinks PLC - Directorate Change

Fevertree DrinksAnnouncement

29/04/2020 07:00

RNS Number : 2343L
  
Fevertree Drinks PLC
  
29 April 2020
  
 

Fevertree Drinks plc
 ("Fever-Tree" or the "Group")
 
Directorate Change
Fever-Tree, the world's leading supplier of premium carbonated mixers, announces that Charles Rolls, co-founder of Fever-Tree, has informed the Board of his intention to step down from his current role as Non-Executive Deputy Chairman at the Group's next Annual General Meeting on 4 June 2020.
Bill Ronald, Chairman of Fever-Tree, said:
"As one of the co-founders of Fever-Tree, Charles's entrepreneurial vision and passion has been integral to the success of the company as it has grown to become the no. 1 premium mixer brand across the globe. 
On behalf of the Board I would like to pass on our thanks for his valued contribution to the Board. He has been an absolute pleasure to work alongside. His experience and passion for Fever-Tree has shone through in all our discussions and although we lose a Board colleague, we keep a good friend."
Tim Warrillow, Co-Founder and CEO, said:
"It really has been a fantastic experience and an enormous amount of fun working with and building the business alongside Charles. He is undoubtedly a great entrepreneur, he was one of the first to successfully breathe life into the premium gin category with Plymouth Gin and then of course Fever-Tree, so Gin & Tonic drinkers around the world owe him a great debt of gratitude. 
 
I will certainly miss working alongside him, but we have not only built a very strong business partnership over the years but also a great friendship and I look forward to many more Gin & Tonics together."
 
Charles Rolls said:
"Co-founding and developing the Fever-Tree brand has been the focus for an immensely satisfying 17 years of business life, from the idea, through to selling our first case, and on to the millions we now sell worldwide. While I am stepping down from the Board, I remain a great supporter and significant shareholder in Fever-Tree and am as passionate about the business as ever. Fever-Tree deals in a world of best before dates and I am happy to be stepping down before I reach mine.
I am leaving a business in robust health. Fever-Tree has a fantastic team in place, led by an inspirational CEO in Tim and I have no doubt there will be many exciting years ahead for the company. I take this opportunity to thank all involved in the success including the worldwide team, our suppliers and our customers."
 
For further information:
 
Fevertree Drinks plc                                                                     
Analysts and Investors
Ann Hyams, Director of Investor Relations                                  +44 (0)7435 828 138
 
Media
Oliver Winters, Director of Communications                                +44 (0)770 332 9024
 
 




Numis Securities - Nominated Adviser and Joint Broker
Garry Levin
Matt Lewis
Hugo Rubinstein
 
Investec Bank plc - Joint Broker
David Flin
Alex Wright
David Anderson


   +44 (0)20 7260 1000
 
 
 
 
   +44 (0)20 7597 5970




Brunswick Group


  +44 (0) 207 404 5959




 Jonathan Glass                                                                           fevertree@brunswickgroup.com
 Fiona Micallef-Eynaud
 Kate Pope
 
Notes to Editors:
 
Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 70 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").
 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
BOAPPUQCCUPUGRR